Market Overview

BMO Capital Maintains Outperform on Isis Pharmaceuticals, Inc., Raises PT to $17.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ISIS

DateFirmActionFromTo
Dec 2014JP MorganMaintainsNeutral
Dec 2014Stifel NicolausMaintainsBuy
Sep 2014Leerink SwannAssumesMarket Perform

View More Analyst Ratings for ISIS
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (ISIS)

Around the Web, We're Loving...

Get Benzinga's Newsletters